Société Acumen Pharmaceuticals, Inc.
Actions
ABOS
US00509G2093
Recherche biotechnologique et médicale
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
3,18 USD | +0,32% | +1,60% | -17,19% |
Métier
Nombre d'employés: 52
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Daniel O'Connell
CEO | Chief Executive Officer | 54 | 01/04/06 |
Jim Doherty
PSD | President | 56 | 01/02 |
Matthew Zuga
DFI | Director of Finance/CFO | 58 | 01/05/21 |
Kasey Spencer
CTO | Chief Tech/Sci/R&D Officer | - | - |
Russell Barton
COO | Chief Operating Officer | 66 | 01/04/19 |
Eric Siemers
CTO | Chief Tech/Sci/R&D Officer | 68 | 01/06/18 |
Alexandria Braun
IRC | Investor Relations Contact | - | 01/09/22 |
Kathleen Pierce
PRN | Corporate Officer/Principal | - | - |
Amber Dilley
PRN | Corporate Officer/Principal | - | 01/01/21 |
Jasna Jerecic
PRN | Corporate Officer/Principal | - | - |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Daniel O'Connell
CEO | Chief Executive Officer | 54 | 01/04/06 |
Director/Board Member | 55 | 01/04/22 | |
Jeffrey Ives
BRD | Director/Board Member | 73 | 01/05/14 |
Sean Stalfort
BRD | Director/Board Member | 54 | 01/10/18 |
Derrell Porter
BRD | Director/Board Member | 53 | 04/01/23 |
Laura Stoppel
BRD | Director/Board Member | 38 | 01/11/20 |
Nathan Fountain
BRD | Director/Board Member | 61 | 01/06/21 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 60 079 778 | 54 596 907 ( 90,87 %) | 0 | 90,87 % |
Coordonnées société
Secteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-17,19% | 190 M | |
+1,77% | 42,75 Md | |
+47,70% | 41,61 Md | |
+12,24% | 41,34 Md | |
-8,83% | 26,59 Md | |
+7,44% | 25,49 Md | |
-23,01% | 18,12 Md | |
+30,56% | 12,24 Md | |
-1,82% | 11,76 Md | |
+8,35% | 11 Md |
- Bourse
- Actions
- Action ABOS
- Société Acumen Pharmaceuticals, Inc.